Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera

Roper KJ. et al, (2023), Scientific Reports, 13

The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.

Thomas TM. et al, (2023), Human vaccines & immunotherapeutics, 19

Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort.

Hanumunthadu B. et al, (2023), BMJ Open, 13

Chronic Hepatitis B Virus Infection and Risk of Stroke Types: A Prospective Cohort Study of 500 000 Chinese Adults.

Hamilton EM. et al, (2023), Stroke

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial.

Hill M. et al, (2023), BMJ Open, 13

A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study

Jackson HR. et al, (2023), The Lancet. Digital health, 5, e774 - e785

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries.

Giersing BK. et al, (2023), The Lancet. Global health, 11, e1819 - e1826

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

Cargill T. et al, (2023), JHEP reports : innovation in hepatology, 5

Long COVID research: an update from the PHOSP-COVID Scientific Summit.

Brightling CE. et al, (2023), The Lancet. Respiratory medicine, 11, e93 - e94

Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.

Bešević J. et al, (2023), Journal of epidemiology and community health

Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.

Weeratunga P. et al, (2023), Nature communications, 14

A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.

Van Puyvelde S. et al, (2023), Nat Commun, 14

Experimental phasing opportunities for macromolecular crystallography at very long wavelengths.

El Omari K. et al, (2023), Commun Chem, 6

Mexican Biobank advances population and medical genomics of diverse ancestries.

Sohail M. et al, (2023), Nature

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions.

Kopycinski J. et al, (2023), Sci Rep, 13

Burkholderia pseudomallei and melioidosis.

Meumann EM. et al, (2023), Nat Rev Microbiol

Cellular iron governs the host response to malaria.

Wideman SK. et al, (2023), PLoS pathogens, 19

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface.

Ni T. et al, (2023), iScience, 26

Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms.

Reinke S. et al, (2023), Cell reports. Medicine

Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes.

Jamwal A. et al, (2023), eLife, 12

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?